Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:
Satyabrata Kar × Effacer les filtres

2 résultats trouvés

Significance of native PEG-PLGA nanoparticles in the treatment of Alzheimer’s disease pathology

At present, there is no effective treatment to arrest the progression of Alzheimer disease (AD) - the most common cause of dementia affecting the elderly. The disease is caused by accumulation of two distinct clumps of proteins in the brain called neuritic plaques and neurofibrillary tangles formed by amyloid beta peptide and tau protein, respectively.

Projet en cours Voir le projet et les chercheurs
TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Concours
Alzheimer Society Research Program (ASRP) 2025-2026
Province
Alberta
DATE DE DÉBUT
2026

Douglas-Bell Canada Brain Bank, an essential platform for brain research in Canada

The Douglas-Bell Canada Brain Bank (DBCBB) houses and manages over 3,000 brains, as well as a large relational database containing demographic, clinical and developmental histories from the donors.

Projet terminé Voir le projet et les chercheurs
TYPE DE SUBVENTION
Subventions de la plate-forme
Domaine de recherche
Santé mentale
Province
Québec
DATE DE DÉBUT
2015